LABORATORY MANAGER POSITION AVAILABLE IN KLEFSTRÖM LAB – RESEARCH PROGRAMS UNIT, MEDICAL FACULTY, UNIVERSITY OF HELSINKI2.12.2019
We are a vibrant research lab of about 16 researchers, including postdocs, graduate students and highly skilled research assisting personnel. Our mission is to translate high-impact laboratory discoveries for the benefit of breast cancer patients. We are seeking an experienced laboratory manager, available immediately, to work at the interface of the Klefström lab and several HiLIFE research services, especially the Helsinki Virus (HelVi) core.
In the Klefström lab the candidate takes care of operational lab management and maintenance tasks, but also participates in a variety of research projects. In the HiLIFE HelVi unit the candidate will mainly focus on the management of the recombinant virus laboratory (BVC) including biosafety training and generation of lenti- and retroviral particles for in vitro and in vivo purposes.
We are looking for a lab manager with a higher vocational diploma or a master’s degree in molecular biology, biotechnology or equivalent. A successful candidate must have 5+ years of work experience in biomedical research, excellent communication skills in Finnish and English, experience in cell culture and molecular and cell biology methods and competence for operational lab management. Ideally, the candidate has a license and previous experience in in vivo methods and BSL2 gene transfer methods. We offer variety of tasks in a teamwork-spirited environment, as well as excellent possibilities to develop skills in vivo techniques and in state-of-the-art functional genomics and translational technologies.
For more information, please visit:
Note! The deadline for the application is December 20th 2019 but the position is filled as soon as a suitable candidate is found.
To apply, please send a cover letter, CV and names of two referees to Research Director Juha Klefström via E-mail: firstname.lastname@example.org with the quoting reference Labmanager2019. Closing date: December 20th, 2019.